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The historical split between the worlds of 
quantitative and molecular genetics hap-
pened over a century ago and was born of 
divided emphasis on naturally occurring 
variation in complex traits and species-typ-
ical phenomena (i.e., assuming all members 
of a species are genetically the same except 
for a few rogue mutations that disrupt nor-
mal processes), respectively (Plomin et al., 
2003).  This  split  allowed  independent 
progress to be made in these two different 
disciplines. Quantitative genetics, through 
family based designs and animal models 
considering  naturally  occurring  genetic 
variation in mice, for example, informed 
much of what we know about heritability 
today. Molecular genetics, in contrast, asked 
whether manipulation of the genetic code, 
such as “knocking out” a gene, could have 
an average effect on organisms via altered 
regulation,  under-  or  over-expression  of 
a  gene.  Efforts  to  reconcile  the  drifting 
apart of these two approaches began in the 
1980s with the advent of DNA markers that, 
because they were polymorphisms in the 
DNA itself rather than in a gene product 
(i.e., red cell blood proteins) held promise 
for identifying quantitative trait loci (QTLs) 
responsible for the inheritance of complex 
traits, such as those in behavioral and psy-
chiatric  genetics.  However,  progress  has 
been slower than expected. In fact, more 
recent  molecular  advances  point  to  how 
quantitative and bioinformatic approaches 
are lagging behind. This recent advent of 
new advanced molecular technologies has 
provided an efficiency in genotyping that 
allows these two complementary fields of 
study to synergize to a greater degree.
The pace at which information about 
genetic  and  epigenetic  modification  is 
being  produced  has  created  a  strain  on 
our available analytic tools when we try to 
consider the impact or significance of this 
genetic information. A myriad of   molecular 
techniques exist to characterize rare and 
common variants, copy number variants 
(CNVs), and even phase (i.e., the combina-
tion of alleles specific to each parental chro-
mosome). This poses a significant challenge 
to the field as far as integrating the effects of 
these individual differences to better under-
stand the biological basis of behavior. For 
example, Lipsky et al. (2009) reported on a 
number of variants in SLC6A4 (the serot-
onin transporter gene) thought to impact 
expression, yet studies are still being pub-
lished with only biallelic characterization 
of 5HTTLPR (a polymorphic region within 
SLC6A4).  Initial  evidence  suggests  that 
DNA methylation of SLC6A4 (Beach et al., 
2011) may also be important. The laborato-
ries publishing biallelic data are frequently 
not lacking in the technology to assess these 
additional genetic and epigenetic variants, 
but combining this information analytically 
without a tremendous cost of power may 
instead be a limiting factor. This points to a 
challenge toward the efficient integration of 
the increasing amount of biological infor-
mation available.
An  additional  challenge  is  to  lever-
age  biological  knowledge  in  the  search 
for genes related to etiology. The agnostic 
approach  used  by  genome-wide  associa-
tion studies (GWAS) has led to important 
breakthroughs, but the enormous multiple 
comparison penalty incurred by this, and 
similar, methods have proven to be a sig-
nificant hurdle. A complementary approach 
that may be useful is to prioritize genes in 
biological pathways known to underlie the 
phenotype of interest. Such an approach can 
capitalize on the economy of genotyping 
afforded by new technology without neces-
sarily paying the statistical penalty for each 
and every potential comparison. Curated 
databases of phenotype-specific collections 
of genes can provide a narrowed focus for 
investigating biological systems. Examples 
of these databases are described in the study 
of cervical cancer and the prostate (Li et al., 
2003; Agarwal et al., 2011). These databases 
provide a gene set that can be examined in 
individuals with genome-wide genotyping 
to obtain the financial advantages of this 
technology while simultaneously increasing 
the likelihood of finding a signal by decreas-
ing the number of comparisons. It is impor-
tant to remember that such an approach 
would be in addition to agnostic strategies, 
as this approach assumes a comprehensive 
biological  knowledge  that  is  unlikely  to 
be the case in behavioral and psychiatric 
phenotypes.  The  evolving  definition  of 
systems biology also includes the merging 
of bioengineering principles with measured 
genotypes in order to begin to consider new 
methods for aggregating risk. For example, 
perturbations in neurotransmitter systems 
may only become evident when multiple 
loci are considered within the system con-
currently. These variants may have additive 
or even multiplicative effects when consid-
ered systematically and may account for 
substantially more variance than present 
analytic methods would suggest.
Adding  difficulty  to  this  already 
Herculean  task  is  the  fact  that  psychiat-
ric  and  behavioral  phenotypes  are  often 
the result of gene products expressed in 
brain. That is, these phenotypes cannot be 
observed directly and are measured by psy-
chometric or diagnostic instruments, which 
are imprecise. Since this tissue is very rarely 
available in living human individuals, the 
advantages afforded to the study of other 
non-brain related medical conditions (e.g., 
characterization of gene expression and epi-
genetic modification in target tissues) are 
not available to our field. Preclinical mod-
els will provide much needed guidance to 
address this issue of limited access to tar-
get tissues, but building readily translatable 
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not to say that there is no utility in   studying 
these processes in human peripheral tis-
sues. Discovery of a peripheral biomarker 
would  have  clinical  utility  inasmuch  as 
those peripheral tissues are available to cli-
nicians to aid in diagnosis and treatment 
planning. However, the inability to access 
the tissue of interest presents an additional 
challenge to the field relative to other areas 
of genetic inquiry (e.g., oncogenetics). It 
seems  likely  that  the  differences  in  gene 
expression  and  epigenetic  modification 
would be specific not only to a brain region, 
but to a specific nuclei within that region. 
If this is true, advances in psychiatric and 
behavioral genetics will almost certainly lag 
behind areas of inquiry into accessible tis-
sues. Neuroimaging techniques that allow 
characterization of gene product levels, for 
example PET, may be of utility in this case 
as the protein product is presumably the 
ultimate consequence of gene expression 
differences and epigenetic modification.
Outcomes such as neuroimaging vari-
ables indicate the very important need of 
careful phenotypic characterization. Using 
attention-deficit  hyperactivity  disorder 
(ADHD) as an example, how can we as a 
field, reconcile the fact that the variance 
explained  by  successfully  located  genetic 
variants for ADHD account for only 1% 
of the variance (Franke et al., 2009), while 
heritability estimates from twin and family 
studies suggest ∼80% (Knopik et al., 2005)? 
This concept of “missing heritability,” i.e., 
the presumed inconsistency between herit-
ability estimates and the ability to explain 
this genetic variance with genetic mark-
ers  (Maher,  2008)  is  non-trivial.  Indeed, 
a  recent  publication  would  suggest  that 
measured genetic variants do not improve 
upon the predictive power of family his-
tory alone when it comes to cardiovascular 
disease (Paynter et al., 2010). Many explana-
tions have been put forward including, but 
not limited to, limitations of genetic mod-
els,  and  statistical  techniques  commonly 
used in association studies (de los Campos 
et al., 2010), gene–environment interaction, 
epistasis, epigenetics, penetrance, rare vari-
ants, incomplete coverage of the gene, and 
genetic  heterogeneity  (see  van  der  Sluis 
et al., 2010). Advances in molecular and 
statistical techniques will assist on one end 
of this problem; however, “at least as impor-
tant to the detection of genetic variants for 
complex traits is the way complex traits are 
in   molecular genetics to find meaningful 
and robust results as we search for genes 
involved in etiology of behavioral and psy-
chiatric  outcomes  and  move  toward  the 
possibility of personalized medicine.
A final challenge to our field is to recall 
that  behavioral  and  psychiatric  genetic 
research not only tell us about genetics but 
it also tells us about environment. In fact, 
they  provide  the  best  possible  evidence 
for  the  importance  of  the  environment. 
That is, if the heritability of a certain trait 
is 50%, the remaining 50% is due to the 
environment. Genes do not equal destiny. 
The environment impacts the development 
of behavioral and psychiatric disorders and 
the environment influences genetics as well 
(Li, 2010). There is a clear need to carefully 
measure the environment and to be mindful 
that many environmental measures show 
genetic influence (Kendler and Baker, 2007). 
Thus,  genetically  sensitive  designs  that 
incorporate  and  investigate  interactions 
and correlations between genes and envi-
ronments are key.
In  sum,  behavioral  and  psychiatric 
genetics is a fairly young field that is expe-
riencing an explosion of growth. Advances 
in molecular analytic processing present 
heretofore unseen possibilities for under-
standing the genetic contribution to behav-
ioral and psychiatric outcomes. It is our job 
to begin to leverage biological knowledge 
in the search for genes related to etiology, 
and to develop new and creative research 
designs  and  techniques  to  integrate  the 
vast amount of biological information into 
models that also include highly refined phe-
notypes and careful measurement of the 
environment. This will, necessarily, have 
to be a team science approach – one that 
includes  contributions  from  clinicians, 
bioengineers,  bioinformaticians,  statisti-
cal geneticists, molecular geneticists, psy-
chometricians,  computational  biologists, 
anthropologists,  evolutionary  biologists, 
among others. It is “early days,” yet excit-
ing days, and I look forward to working 
alongside all of you as we embrace these 
challenges together.
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